InterCure Ltd.
INCR
$1.60
$0.053.23%
NASDAQ
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -1.78% | -30.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.78% | -30.08% | |||
| Cost of Revenue | -1.78% | -22.39% | |||
| Gross Profit | -1.78% | -46.29% | |||
| SG&A Expenses | -1.78% | -12.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -1.79% | 22.44% | |||
| Total Operating Expenses | -1.78% | -19.15% | |||
| Operating Income | 1.79% | -210.95% | |||
| Income Before Tax | 1.78% | -7,774.12% | |||
| Income Tax Expenses | -1.77% | 157.05% | |||
| Earnings from Continuing Operations | 1.78% | -981.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -1.78% | -87.62% | |||
| Net Income | 1.78% | -769.41% | |||
| EBIT | 1.79% | -210.95% | |||
| EBITDA | 5.40% | -151.60% | |||
| EPS Basic | 1.80% | -846.27% | |||
| Normalized Basic EPS | 1.87% | -- | |||
| EPS Diluted | 1.75% | -846.27% | |||
| Normalized Diluted EPS | 1.87% | -- | |||
| Average Basic Shares Outstanding | 0.00% | -10.15% | |||
| Average Diluted Shares Outstanding | 0.00% | -10.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||